ENTRY       D10921                      Drug
NAME        Daxibotulinumtoxin A (USAN);
            Daxibotulinumtoxin A-lanm;
            Daxxify (TN)
FORMULA     C6708H10359N1729O1995S32
EXACT_MASS  148080.3354
MOL_WEIGHT  148171.4934
EFFICACY    Antimigraine, Skeletal muscle relaxant
COMMENT     Treatment of galbellar lines, cervical dystonia, lateral canthal lines, migraine headaches and hyperhidrosis
TARGET      SNAP25 [HSA:6616] [KO:K18211]
  PATHWAY   hsa04721(6616)  Synaptic vesicle cycle
BRITE       USP drug classification [BR:br08302]
             Dermatological Agents
              Dermatological Agents, Other
               Dermatological Agents, Miscellaneous
                Daxibotulinumtoxin A
                 D10921  Daxibotulinumtoxin A (USAN)
            Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Organismal systems
               Nervous system
                SNAP25
                 D10921  Daxibotulinumtoxin A (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D10921
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D10921
DBLINKS     CAS: 93384-43-1
            PubChem: 342581778
///
